AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34

Authors: SENN S
Citation: S. Senn, APPLYING RESULTS OF RANDOMIZED TRIALS TO PATIENTS - N OF 1 TRIALS ARENEEDED, BMJ. British medical journal, 317(7157), 1998, pp. 537-537

Authors: SENN S
Citation: S. Senn, MORTALITY AND DISTRIBUTION OF INCOME - SOCIETIES WITH NARROWER INCOMEDISTRIBUTIONS ARE HEALTHIER, BMJ. British medical journal, 316(7144), 1998, pp. 1611-1611

Authors: SENN S
Citation: S. Senn, TOO SOON TO MARKET - STATISTICAL ASPECTS OF RESEARCH DONE OUTSIDE PHARMACEUTICAL-INDUSTRY COULD BE IMPROVED, BMJ. British medical journal, 316(7126), 1998, pp. 228-228

Authors: SENN S
Citation: S. Senn, SOME CONTROVERSIES IN PLANNING AND ANALYZING MULTICENTER TRIALS, Statistics in medicine, 17(15-16), 1998, pp. 1753-1765

Authors: SENN S
Citation: S. Senn, IN THE BLOOD - PROPOSED NEW REQUIREMENTS FOR REGISTERING GENERIC DRUGS, Lancet, 352(9122), 1998, pp. 85-86

Authors: SENN S
Citation: S. Senn, ARE PLACEBO RUN INS JUSTIFIED, BMJ. British medical journal, 314(7088), 1997, pp. 1191-1193

Authors: SENN S
Citation: S. Senn, STATISTICAL BASIS OF PUBLIC-POLICY - PRESENT REMEMBRANCE OF PRIORS PAST IS NOT THE SAME AS A TRUE PRIOR, BMJ. British medical journal, 314(7073), 1997, pp. 73-73

Authors: SENN S HARRELL F
Citation: S. Senn et F. Harrell, ON WISDOM AFTER THE EVENT - DISSENT, Journal of clinical epidemiology, 50(7), 1997, pp. 749-751

Authors: SENN S
Citation: S. Senn, THE CASE FOR CROSS-OVER TRIALS IN PHASE-III, Statistics in medicine, 16(17), 1997, pp. 2021-2022

Authors: SENN S
Citation: S. Senn, TESTING FOR INDIVIDUAL AND POPULATION EQUIVALENCE BASED ON THE PROPORTION OF SIMILAR RESPONSES, Statistics in medicine, 16(11), 1997, pp. 1303-1305

Authors: BUTLER R FITZGIBBON C GARDNER J MACFARLANE A SMALLS M DRAPER D GALBRAITH R EASTWOOD A SHELDON TA SMITH P GALBRAITH JI COPAS JB KAPADIA R SCHAGEN I BRAND R LOUIS TA LEYLAND AH GORE S GOODHARDT G SENN S LANGFORD IH BARTHOLOMEW D LONGFORD NT DIAMOND I STEELE F NORMAND SL MCKEE M ABRAMS KR LAMBERT PC CHATFIELD C CHRISTIANSEN CL ECOB R FIELDING A HARRELL FE KENDRICK S MUXWORTHY D RUSSELL D RUSSELL I SNIJDERS TAB SPENCER NH TARNOWMORDI W
Citation: R. Butler et al., LEAGUE TABLES AND THEIR LIMITATIONS - STATISTICAL ISSUES IN COMPARISONS OF INSTITUTIONAL PERFORMANCE - DISCUSSION, Journal of the Royal Statistical Society. Series A. Statistics in society, 159, 1996, pp. 409-443

Authors: BARTHOLOMEW DJ HEALY MJR HUTTON JL CAMERON PJ SENN S KEENE O STINE WW WALLACE CS ATKINSON AC RENNOLLS K BARNARD GA COX DR COX NJ DAVISON ML GOWER J LINDSEY JK MICHELL J MOLENAAR IW NIEDEREE R OHAGAN T SPRENT P STANGHELLINI E SUTCLIFFE JP VELLEMAN PF WILKINSON L YU KM ZUMBO BD
Citation: Dj. Bartholomew et al., STATISTICS AND THE THEORY OF MEASUREMENT - DISCUSSION, Journal of the Royal Statistical Society. Series A. Statistics in society, 159, 1996, pp. 473-492

Authors: SENN S
Citation: S. Senn, RELATION BETWEEN TREATMENT BENEFIT AND UNDERLYING RISK IN METAANALYSIS - STANDARD OF LABEL INVARIANCE SHOULD NOT ABANDONED, BMJ. British medical journal, 313(7071), 1996, pp. 1550-1550

Authors: SENN S
Citation: S. Senn, SOME STATISTICAL ISSUES IN PROJECT PRIORITIZATION IN THE PHARMACEUTICAL-INDUSTRY, Statistics in medicine, 15(24), 1996, pp. 2689-2702

Authors: SENN S
Citation: S. Senn, A PERSONAL VIEW OF SOME CONTROVERSIES IN ALLOCATING TREATMENT TO PATIENTS IN CLINICAL-TRIALS, Statistics in medicine, 15(1), 1996, pp. 113-114

Authors: SENN S
Citation: S. Senn, A PERSONAL VIEW OF SOME CONTROVERSIES IN ALLOCATING TREATMENT TO PATIENTS IN CLINICAL-TRIALS - REPLY, Statistics in medicine, 15(1), 1996, pp. 114-116

Authors: GRIEVE AP SENN S
Citation: Ap. Grieve et S. Senn, A COMMENT ON INTERIM ANALYSES IN CROSSOVER TRIALS, Biometrics, 52(4), 1996, pp. 1515-1518

Authors: SENN S BAKSHI R EZZET N
Citation: S. Senn et al., N OF 1 TRIALS IN OSTEOARTHRITIS - CAUTION IN INTERPRETATION NEEDED, BMJ. British medical journal, 310(6980), 1995, pp. 667-667

Authors: SENN S
Citation: S. Senn, A PERSONAL VIEW OF SOME CONTROVERSIES IN ALLOCATING TREATMENT TO PATIENTS IN CLINICAL-TRIALS, Statistics in medicine, 14(24), 1995, pp. 2661-2674

Authors: SENN S
Citation: S. Senn, IN DEFENSE OF ANALYSIS OF COVARIANCE - REPLY, Statistics in medicine, 14(20), 1995, pp. 2283-2285

Authors: GRIEVE AP POCOCK SJ ABRAMS K ASHBY D HEALY MJR JENNISON C LEWIS JA LINDLEY DV MACHIN D NEWMAN GB BATHER JA BAILEY RA EVANS SJW KEIDING N MATTHEWS JNS GORE SM SENN S HERSON J TURNBULL BW ALTMAN DG ARMITAGE P ATKINSON AC BERRY DA BUYSE ME CARLIN BP DEMETS DL DEMPSTER AP DUNSTAN FDJ ELLENBERG SS FAYERS P GAIL MH GEORGE SL GREENHOUSE JB WASSERMAN LA HARRELL FE JOSEPH L SHAPIRO SH KADANE JB LEHMANN HP MARUBINI E MARIANI L PATER JL PETTIT LI YOUNG KDS ROSNER GL WHITEHEAD J WIEAND HS
Citation: Ap. Grieve et al., BAYESIAN APPROACHES TO RANDOMIZED TRIALS - DISCUSSION, Journal of the Royal Statistical Society. Series A. Statistics in society, 157, 1994, pp. 387-416

Authors: SENN S RICHARDSON W
Citation: S. Senn et W. Richardson, THE FIRST T-TEST, Statistics in medicine, 13(8), 1994, pp. 785-803

Authors: SENN S
Citation: S. Senn, FISHER GAME WITH THE DEVIL, Statistics in medicine, 13(3), 1994, pp. 217-230

Authors: SENN S
Citation: S. Senn, IMPORTANCE OF TRENDS IN THE INTERPRETATION OF AN OVERALL ODDS RATIO IN THE METAANALYSIS OF CLINICAL-TRIALS, Statistics in medicine, 13(3), 1994, pp. 293-296

Authors: SENN S
Citation: S. Senn, METHODS FOR ASSESSING DIFFERENCE BETWEEN GROUPS IN CHANGE WHEN INITIAL MEASUREMENT IS SUBJECT TO INTRAINDIVIDUAL VARIATION, Statistics in medicine, 13(21), 1994, pp. 2280-2283
Risultati: 1-25 | 26-34